Health

Results: 2365-2376 of 7511

Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension

Diamyd Medical highlights opportunity in Type 1 Diabetes prevention, adult-onset market, and upcoming Phase 3 readout

PR Newswire associated0

ToolGen Files Patent Infringement Lawsuit Against Vertex in the United Kingdom

PR Newswire associated0

K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate with Ultra-High Drug Loading Capacity Demonstrates Superior Efficacy in EGFR-Expressing Solid Tumors

PR Newswire associated0

Declaration on longevity and precision medicine launched at Abu Dhabi Global Health Week

Univfy® Publishes Study in Nature Communications, Validates Univfy Artificial Intelligence (AI)/Machine Learning (ML) Platform's Superior In Vitro Fertilization (IVF) Live Birth Predictions, Key to Improving IVF Access, Affordability and Clinical Outcomes

VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model

PR Newswire associated0

Alkermes to Report First Quarter Financial Results on May 1, 2025

PR Newswire associated0

Burnett Homeopathy Private Limited Convenes Global Experts at World Homoeopathy Summit 3 in Köthen, Germany

Sanoculis Receives CE Mark for MINT® Product for the Treatment of Glaucoma

Patients urged to check packs of blood pressure medicine lercanidipine after labelling error

Left: Keitaro Iwaki, President & Representative Director, SPERA PHARMA; Right: Jun Kawakami, President & CEO, Rigaku

Rigaku and SPERA PHARMA Initiate Strategic Partnership to Advanced Pharmaceutical Development